Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

13239E

Centrisart® I centrifugal ultrafiltration unit

MWCO 10 kDa

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Codice UNSPSC:
41104916
NACRES:
NB.24

Materiali

polystyrene housing
polystyrene outer tube
polysulfone membrane

Sterilità

non-sterile

Confezionamento

pack of 12 tubes

Produttore/marchio commerciale

Sartorius 13239E

Parametri

2000 × g max. force (fixed angle)
2500 × g max. force (swinging bucket)

Superficie filtrante

0.79 cm2

Largh. × lungh. tubo campione esterno

14 mm × 93 mm

Dimens. tubo

~15 mL

Volume d’esercizio × volume concentrato

2.5 mL × 100

Dimensione pori

10 kDa MWCO

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

  • Centrisart® I centrifugal ultrafiltration unit is ideal for the separation of small-volume proteins from low molecular weight substances in biological samples.
  • The unit works in the direction opposite to centrifugal force which prevents premature filter blockage.
  • This versatile device is utilized in both fixed-angle or swinging-bucket rotors that hold standard 15 mL tubes.
  • The product is collected in the easily accessible floater insert tube.

Applicazioni

  • Protein removal from blood samples
  • Drug binding studies
  • Cleaning of liposomes (cell lysates)

Note legali

Centrisart is a registered trademark of Sartorius Stedim Biotech GmbH

Choose from one of the most recent versions:

Certificati d'analisi (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Agnieszka Smolinska et al.
Analytical and bioanalytical chemistry, 403(4), 947-959 (2012-03-08)
Because cerebrospinal fluid (CSF) is the biofluid which interacts most closely with the central nervous system, it holds promise as a reporter of neurological disease, for example multiple sclerosis (MScl). To characterize the metabolomics profile of neuroinflammatory aspects of this
Wenyi Zheng et al.
Scientific reports, 10(1), 1274-1274 (2020-01-29)
Selenocompounds (SeCs) are promising therapeutic agents for a wide range of diseases including cancer. The treatment results are heterogeneous and dependent on both the chemical species and the concentration of SeCs. Moreover, the mechanisms of action are poorly revealed, which most

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.